NASDAQ: GANX Rewriting the Future of Treatment for Genetically Driven Diseases A clinical-stage biotech developing breakthrough therapies designed to restore protein function and fight neurodegenerative and rare diseases. Chart Website LATEST NEWS Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026 READ MORE 5 Reasons Gain Therapeutics Is Positioned for Future Growth Root… Continue reading A Next-Generation Approach to Structurally Driven Disease
Month:
Exploring a Small-Cap Growth Company Focused on Emerging Opportunities
CSE: GOAT.CN A Public Investment Issuer Focused on Strategic Capital Deployment A Canadian-listed investment vehicle targeting opportunities across emerging and evolving sectors. Chart Website LATEST NEWS GOAT INDUSTRIES TO SHOWCASE BETSOURCE-ENHANCED BKFC APP EXPERIENCE DURING KNUCKLEMANIA VI READ MORE ABOUT GOAT INDUSTRIES LTD. GOAT Industries Ltd is a publicly listed investment issuer trading on the… Continue reading Exploring a Small-Cap Growth Company Focused on Emerging Opportunities
Powering Voter Outreach in a Rapidly Expanding Market
NASDAQ RESERVED: GOTV Powering Democracy Through Scalable Political Technology A technology platform serving political campaigns nationwide and operating within the growing U.S. election spending ecosystem. Website LATEST NEWS FullPAC CEO to Outline Future of Election Tech at 2026 Pollie Awards & Conference READ MORE About FullPAC (NASDAQ RESERVED: GOTV) FullPAC is a political technology company… Continue reading Powering Voter Outreach in a Rapidly Expanding Market
The Evolving Landscape of Metabolic and Cardiometabolic Disease
NASDAQ: MTVA A Concentrated Approach to Cardiometabolic Therapeutic Innovation MetaVia (NASDAQ: MTVA) offers investors a targeted opportunity to gain exposure to the advancing cardiometabolic therapeutic landscape addressing large and growing global health challenges. Chart Website LATEST NEWS MTVA: Positive Results for 48 mg Cohort in Phase 1b Trial of DA-1726 READ MORE About MetaVia (NASDAQ:… Continue reading The Evolving Landscape of Metabolic and Cardiometabolic Disease
